Latest Breaking News On - Haibo qiu - Page 1 : comparemela.com

Olverembatinib Demonstrates Early Activity, Tolerability in SDH-deficient GIST

Olverembatinib showed antitumor activity in patients with TKI-resistant, SDH-deficient GISTs and paraganglioma.

China
Guangzhou
Guangdong
Haibo-qiu
Ascentage-pharma
Sun-yat-sen-university-cancer-center

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and.

Zhejiang
China
Hong-kong
United-states
Hangzhou
Suzhou
Jiangsu
Chicago
Illinois
Guangzhou
Guangdong
Jilin

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
balticbusinessnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balticbusinessnews.com Daily Mail and Mail on Sunday newspapers.

Guangzhou
Guangdong
China
Hangzhou
Zhejiang
Jilin
Hong-kong
United-states
Australia
Suzhou
Jiangsu
Mccormick-place

ASCO 2024 | Ascentage Pharma To Present Four Studies, Including An Oral Report Featuring The Latest Data Of Olverembatinib In SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma To Present Four Studies, Including An Oral Report Featuring The Latest Data Of Olverembatinib In SDH-Deficient GIST
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Melbourne
Victoria
Australia
Rockville
Illinois
United-states
Chicago
Guangdong
Jilin
China
Mccormick-place
Guangzhou

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST

ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Guangdong
Jilin
China
Hangzhou
Zhejiang
United-states
Hong-kong
Suzhou
Jiangsu
Melbourne
Victoria
Australia